Form D · Pharmaceuticals
LYCERA CORP
Ann Arbor, MI · CIK 0001382268
Offering snapshot reported Jun 22, 2015 · SEC filing
- Reported sold
- $29.9M Indefinite offering
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 12, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 22, 2015 | Initial | $29,892,748 | No comparison | 22 | SEC filing |
| Apr 4, 2014 | Initial | $4,000,000 | No comparison | 6 | SEC filing |
| Oct 21, 2013 | Initial | $5,000,000 | No comparison | 5 | SEC filing |
| Jun 28, 2012 | Amendment | $33,917,556 | $20,999,999vs Apr 15, 2009 | 17 | SEC filing |
| Apr 15, 2009 | Initial | $12,917,557 | No comparison | Not reported | SEC filing |
| Nov 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 20, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-242213
Conversion of Convertible Promissory Notes for Series B Preferred Stock and the purchase of Series B-1 Preferred Stock for cash.
Source: Form D, filed Jun 22, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kristina Burow | Director |
| Kristina Burrow | Director |
| David Canter | Director |
| Steven Gillis | Director |
| Steve Gillis | Director |
| Gary Glick | Director, Executive |
| Michael Hayden | Director |
| Robert Kamen | Director |
| Nina Kjellson | Director |
| Jeffrey Leiden | Director |
| Timothy Mayleben | Director |
| Tim Mayleben | Director |
| Kathleen M. Metters | Director, Executive |
| Paul Sekhri | Executive |
| Michael Steinmetz | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2800 Plymouth Road, Ncrc Building 26
Ann Arbor, MI, 48109
Ann Arbor, MI, 48109